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Abstract: Forensic practice in the Republic of Serbia faced the illegal produc-
tion of amphetamine for the first time in 2003. This paper presents the results 
of the chemical characterization of 32 batches of amphetamine samples from 
three separate cases, for the purpose of identification of the active components 
and additives. Through the profiling of impurities of all samples, using gas 
chromatography/mass spectrometry (GC/MS), 30 compounds associated with 
amphetamine were identified. The results of the analysis of powder tartrate, 
sulfate and phosphate salts of amphetamine, as well as variously formulated 
tablets are presented in this study. The analyses showed that the amphetamines 
were synthesized by the Leuckart method in all cases. 
Keywords: amphetamine; impurity profiling; Leuckart synthesis. 
INTRODUCTION 
Abuse of amphetamine type stimulants (ATS) is on the rise worldwide. Ac-
cording to UNODC data, the number of ATS users is larger than the number of 
heroin and cocaine users combined. The situation is similar on the illegal market 
of the Republic of Serbia: ATS abuse is increasing; ecstasy tablets containing the 
active agent MDMA are the most common, amphetamines are less common, 
while abuse of methamphetamine is negligible. According to 2003 data, Europe 
is considered the largest consumer and producer of amphetamine. Reports sub-
mitted to Interpol by East European member countries mention the production of 
amphetamine tablets intended for the illicit market in the Middle Eastern coun-
tries. Three illegal amphetamine laboratories in parallel producing tablets were 
discovered on the territory of the Republic of Serbia in 2003. According to UN 
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data, one of them was among the largest discovered to date in Europe, with an 
estimated production of several tons of amphetamine salts. All the discovered 
tablets had the characteristic "captagon" logo on them, and were never again 
found on the illegal market of the Republic of Serbia. 
Amphetamine ((±)-2-amino-1-phenylpropane), one of the oldest synthetic 
stimulants, was first synthesized in 1887. The synthesis of amphetamine by the 
Leuckart method1 is most commonly performed illegally and is accompanied by 
varying levels of impurities in the final product, depending on the quality of the 
starting materials, route of synthesis, reaction conditions, extent of purification of 
the final product and, above all, on the skills of the clandestine chemist.2–8 
"Captagon" is a trademark of a drug containing the active substance fen-
ethylline hydrochloride, a theophylline derivative of amphetamine having effects 
similar to those of amphetamine. It is used in medicine as a medicament for hy-
peractivity disorders in children, but is also subject to abuse.9 The primary mar-
ket for fenethylline has traditionally been countries located on the Arabian Penin-
sula, namely Saudi Arabia, Kuwait and Qatar, where fenethylline is one of the 
most popular drugs among the younger population.10 Tablets with the "Capta-
gon" logo have also been seized in Turkey, where illegal production was also 
discovered.11 In Jordan, a transient country for illicit Captagon tablets, geogra-
phically located between the European countries, where they are produced, and 
the Arabian Peninsula consuming countries, multiple capture of such tablets have 
been accomplished. Alabdalla in his study determined the chemical composition 
of those seized tablets.12 The common point of all the published analyses of "Cap-
tagon" tablets is the absence of fenethylline and the presence of amphetamine in 
combination with caffeine, quinine and several other substances.10–12 
In this study, the powder substances and tablets seized in police raids on 
illegal laboratories were analyzed and compared. The results of routine chemical 
characterization based on the identification of components through FTIR and 
GC/MS, as well as the results of the determination of organic impurities, in order 
to determine the route of synthesis, through GC/MS13,14 are quoted. This is one 
of the first studies of this type conducted in our laboratory; therefore, identifi-
cation was made through comparison with bibliographical data15–20 and NIST 
database spectra, without any reference standards. 
EXPERIMENTAL 
Materials and reagents 
In this study, 32 types of amphetamine samples from three different criminal cases of il-
legal production on the territory of the Republic of Serbia were analyzed. From case I, 3 kinds 
of powder samples (I-10–I-12, from seizures of 6.74, 2.36 and 48 kg, respectively) and 20 
types of tablets (total weight of 33.06 kg) of various colors and forms were analyzed (I-1–I-9 
and I-13–I-23). From case II, 7 white-colored powder samples (4 kg in 7 separate packets, II-1– 
–II-7), as well as tablets (total weight of 12 kg, II-8) were analyzed. From case III, tablets (III-1) 
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with the same appearance and content, seized in the tablet production plant, were analyzed. 
The average weight of a tablet from all three seized batches was 170 mg, while average di-
mensions were 8 mm in diameter and 3.5 mm in thickness. They were of different colors 
(brown, cocoa, beige, yellow, pink, pastel pink, ivory, gray and white), and were marked with 
the "Captagon" logo on one side, and scored on the other, as shown in Fig. 1. 
Fig. 1. Photograph of a tablet produced in Serbia. 
The D,L-amphetamine reference standard (C9H13N×HCl) was obtained from the UN 
(Lipomed, Switzerland). All the reagents used in the study (chloroform, toluene, octadecane, 
KBr, tris, water) were of analytical grade purity. 
Instrumentation 
Infrared spectra (450–4000 cm-1) of the compounds were obtained using the KBr disc 
technique or thin films on KBr plates; Thermo Nicolet 5700 and Spectrum One (Perkin–El-
mer) instruments were used for the measurements. 
Gas chromatography/mass spectrometry was performed using a ThermoFinnigan TraceGC 
gas chromatograph interfaced with an ion trap PolarisQ mass spectrometer. One microliter of 
each extract was injected in the splitless mode using a CombiPal autosampler. The column 
was an Rtx-5MS capillary column (crossbond 5 % diphenyl–95 % dimethylpolysiloxane); 30 m 
(L)×0.32 mm (i.d.) with a 0.25 µm film thickness. The oven temperature was programmed as 
follows: initial temperature 90 °C, delay for 1.0 min, ramp to 300 °C at a rate of 8.0 °C min-1, 
held for a further 10 min). The injection port and transfer line temperatures were set to 250 
and 275 °C, respectively. The ion source temperature was set at 230 °C, while the flow rate of 
He carrier gas was fixed at 1.0 ml min-1. The mass spectrometer was tuned to electron impact 
ionization (EI); the mass spectra were recorded in intervals from m/z 30 to 300. 
Sample preparation 
Standard extraction procedure. Preparation of the sample for conventional chemical cha-
racterization was made according to the traditional fractional extraction method, depending on 
the solubility specific to a particular class of compounds, followed by successive measure-
ment of the extracts or residues by FTIR and/or GC/MS. Traditional wet-chemistry anion tests 
were used to determine sulfate, phosphate and tartrate.13 
Extraction of impurities. Amphetamine powder samples (200±5 mg of each sample) and 
thoroughly crushed whole pills (average mass 170±5 mg) were dissolved in Tris buffer (4.0 ml, 
0.10 M, pH 8.10) and the mixture was shaken for 10 min. Toluene (200 µl) containing 
octadecane as internal standard (10 µg ml-1) was added and the test tube shaken for a further 
10 min and then centrifuged at 3000 rpm for 3.0 min. An aliquot of the organic layer was ana-
lyzed by GC/MS. 
RESULTS AND DISCUSSION 
Powder substances from case I were identified by infrared spectrometry as 
amphetamine tartrate (I-10), amphetamine sulfate (I-11) and mixture of amphe-
tamine sulfate and lactose (I-12), while all 7 powder substances from case II (II-1–
–II-7) were amphetamine phosphate salts. The infrared spectrum of the ampheta-
mine tartrate salt (detected for the first time in Serbia) is shown in Fig. 2. 
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Fig. 2. Infrared spectrum of am-
phetamine tartrate. 
The physical characteristics and logo of the tablets were almost identical in 
all three cases. Amphetamine (in concentrations ranging from 4.0 to 25 %) was 
identified in all the analyzed tablets. The chemical characterization of the illegal 
amphetamine tablets produced in Serbia is shown in Table I; wherein the 
composition of selected tablets of heterogeneous contents are shown from case I, 
while II-8 and III-1 refer to cases II and III, where there was no difference in their 
content and appearance. 
TABLE I. Substances detected in nine tablets as representative of the total seized batch 
Amphetamine Adulterant Diluents 
Sample Color Sul-
fate 
Tar-
trate 
Phos-
phate 
Caf-
feine
Qui-
nine
Amino-
-pyrine 
Rani-
tidine 
Lac-
tose
Microcr. 
cellulose Others
a 
I-4 Pink √b   √  √  √ √ √ 
I-5 White √       √ √ √ 
I-14 Pastel 
pink 
√ √   √   √ √ √ 
I-20 Gray √    √ √  √ √  
I-21 Beige √   √ √  √ √ √ √ 
I-22 Ivory √ √  √ √ √  √ √ √ 
I-23 Yellow √ √  √ √   √ √  
II-8 Pink   √ √ √   √  √ 
III-1 Pink   √ √ √   √  √ 
aPovidone and/or starch/stearic acid/glucose; bdetected 
White tablets (5 kinds), which were all from case I but found at different lo-
cations in the tablet producing plant, contained solely amphetamine sulfate in higher 
concentrations, whereas the colored tablets (17 kinds) contained a mixture of am-
phetamine salts, caffeine and quinine, and, in some cases, aminopyrine and rani-
tidine. Lactose, microcrystal cellulose, povidone and/or starch/stearic acid/glu-
cose were used as excipients. 
It is interesting that within a single clandestine laboratory various salts and 
huge variations in the diluents, adulterants and excipients were found. 
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A complete analysis of the impurities present was performed by GC/MS. 
The compounds were identified based on comparison with reference spectra (Wi-
ley and NIST database) or comparing the ion chromatograms with the spectra 
from the available literature. 
The chromatograms of the accompanying impurities in three types of am-
phetamine salt samples are shown in Fig. 3. 
 
Fig. 3. Chromatograms between 6 and 28 min of impurities in tartrate, sulfate and phosphate 
amphetamine salts with expansion of the data between 19.30 and 20.70 min, 
and the identity of the main peaks. 
A list of the main impurities and their characteristic mass ions found as a re-
sult of GC/MS analysis is given in Table II. The identification numbers asso-
ciated with the compounds is connected with the annotated peaks in Figs. 3 and 4. 
Some of the listed compounds were not visible in the chromatograms (Figs. 
3 and 4) because they were either not present or present in only trace amounts in 
the selected samples. Impurity origins quoted in Table II are not exclusive. 
All the samples analyzed in this study contained benzyl methyl ketone 
(BMK, Rt = 5.3 min), identified using extracted ion chromatograms, although its 
peak was irresolvable from the much larger amphetamine peak. The main pro-
duct, amphetamine (Rt = 5.3 min) is not visible within the time range presented in 
Figs. 3 and 4. 
Compounds which eluted at 10.51 and 10.84 min in an abundance ratio of 
about 5:1 were identified as 4-methyl-5-phenylpyrimidine (8) and 4-benzylpyri-
midine (9). These are impurities connected entirely with the Leuckart method of 
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amphetamine synthesis.8 The peak eluting at 11.13 min retention time is N-for-
mylamphetamine (10), which can, when remaining in large quantities as a conse-
quence of incomplete hydrolysis, mask the presence of pyrimidine derivatives 
under the given chromatographic conditions. 
TABLE II. Compounds detected in samples through gas chromatograph/mass spectrometry 
Compound m/z Rt Origin 
Amphetamine 44, 91, 120 5.35 Major product 
Benzyl methyl ketone (P2P) 43, 91, 134 5.35 Precursor 
Methamphetamine 58, 91, 92, 65 6.08 By-product 
N-Ethylamphetamine 72, 44, 91 6.84 By-product 
N,N-Dimethylamphetamine 72, 91, 65 7.01 By-product 
Isopropylamphetamine 86, 44, 91, 120 7.22 By-product 
Ephedrine/pseudoephedrine 58, 77, 105 9.04 Adulterant/ 
/contaminant 
4-Methyl-5-phenylpyrimidine 170, 169, 
102, 115 
10.51 By-product 
4-Benzylpyrimidine 169, 170, 
115, 91 
10.84 By-product 
N-Formylamphetamine 118, 72, 91, 44 11.13 Intermediate 
Unidentified-11 198, 197, 
115, 116 
11.54 Unknown 
N-Formylmethamphetamine 86, 58, 118 11.91 Intermediate 
Unidentified-13 100, 72, 44 12.58 Unknown 
1,3-Diphenyl-2-propanone 91,65, 119, 210 13.53 Impurity BMK 
(P2P) 
N-(β-Phenylisopropyl)benzaldimine 132, 105, 91 14.68 By-product 
Octadecane 57 14.90 IS 
1,3-Diphenylisopylamine 120, 91, 103 15.34 By-product 
Caffeine 194 15.84 Adulterant 
α-Methyldiphenethylamine 148, 105, 91 16.40 By-product 
Bis(β-phenylisopropyl)aminea 162, 91, 119, 44 16.42, 16.50 By-product 
Aminopyrine 231, 97, 56 17.06 Adulterant 
N,N-Bis(β-phenylisopropyl)methylaminea 176, 91, 58, 119 18.03, 18.13 By-product 
N-benzoylamphetamine 105, 148, 
77, 118 
18.62 By-product 
Unidentified-24 44, 91, 162, 65 19.10 Unknown 
Pyridine P1b 273 19.51 By-product 
Pyridine P2b 272, 273 19.60 By-product 
Pyridine P3b 258, 259 19.73 By-product 
Pyridine P4b 258 19.85 By-product 
Pyridine P5b 258 19.99 By-product 
Pyridine P6b 272 20.27 By-product 
N,N-Bis(β-phenylisopropyl)formamidea 190, 91, 
119, 162 
21.20, 21.56 By-product 
Unidentified-32 91, 132, 
133, 222 
26.24 Unknown 
Quinine 136 26.69 Adulterant 
aStereoisomers; btemporarily identified compound 
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Fig. 4. Profiling of selected tablets with the identity of the major peaks. 
Three pairs of peaks eluting at 16.42/16.50, 18.03/18.13, and 21.20/21.56 
min show the elution characteristics of non-resolved stereoisomers and the mass 
spectra of bis(β-phenylisopropyl)amine (20), N,N-bis(β-phenylisopropyl)methyl-
amine (22) and N,N-bis(β-phenylisopropyl)formamide (31). 
As by-products in the analyzed samples, methamphetamine (Rt = 6.13 min), 
N-formyl methamphetamine (Rt = 11.91 min), N-ethylamphetamine (Rt = 6.84 min), 
N,N-dimethylamphetamine (Rt = 7.01 min) and isopropylamphetamine (Rt = 7.22 min) 
were also found. 
The origin of 1,3-diphenyl-2-propanone (Rt = 13.53 min) is the impurity of 
the starting material BMK (P2P) and it is supposed that 1,3-diphenyl-isopropyl-
amine (Rt = 15.34 min) was formed in the course of amphetamine synthesis as 
the aminated derivative of the above mentioned ketone. 
For the following group of compounds, the identification approach had a 
temporary character: in the time interval between 19 and 21 min (Fig. 3), a group 
of compounds elute showing poor mass spectra with fragmentation with base 
peaks at m/z 258, 259 or 272, 273 (Fig. 5). The high abundance of such ions 
could indicate the presence of very stable molecules which do not readily un-
dergo the fragmentation process. The most likely structure of these molecules is 
composed of the so-called pyridines, well known from the literature on the prepa-
ration of amphetamine by the Leuckart synthesis as "high-boiling pyridines".3,16–18 
Through extraction of ion m/z 105, a chromatogram was obtained with the 
peaks of α-methyldiphenethylamine (Rt = 16.40 min) and N-benzoylamphe-
tamine (Rt = 18.62 min).18,19 
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Fig. 5. Mass spectra of the pyridine derivatives with Mr = 259 and 273 g mol-1. 
The occurrence of Schiff bases in illicit amphetamine preparations has al-
ready been published by Theeuwen and Verweij.20 These authors stated that 
imines could be found in every amphetamine synthesis in which P2P was em-
ployed as a precursor. Due to their instability in strongly acid environment, after 
the second step of the Leuckart synthesis, detection of imines in relatively small 
quantities is to be expected. N-(β-Phenylisopropyl)benzalimine was also identi-
fied in the tablets, although only in traces, at 14.68 min. 
Neither a comprehensive bibliographical search, nor spectral analysis, resul-
ted in the final identification of compounds marked with the numbers 11, 13, 24 
and 32, the mass spectra of which are shown in Fig. 6. Unidentified compound 
11, detected in all the samples, has the fragmentation of 5-benzyl-2,3-dimethyl-
pyrazine or 2-benzyl-5,6-dimethylpyrazine; as for compound 13, it is assumed to 
be N,N-diethylamphetamine. The unidentified compound 24 is also noteworthy; 
in all the analyzed samples it eluted at 19.09 min, with a fragmentation very simi-
lar to that of compound 20, but with different relative ion ratios. 
Although the amphetamine sulfate and tartrate originated from the same ille-
gal production, a difference in their impurity levels was evident. It was revealed 
that although compound 20 was the dominant impurity in amphetamine sulfate, it 
was only found in traces when compared to compound 10 and its methylized (22) 
and formylized (31) derivatives in the tartrate salt. 
The amphetamine phosphate samples from case II were poorer and only 
compound 20 was detected as the main impurity, with traces of compound 8. The 
absence of compound 10 was easily noticeable, which corresponds to earlier fin-
dings (internal unpublished results) connected with the establishment of proofs in 
the production plant itself, which indicated a thorough approach to the synthesis, 
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where control of the hydrolysis stage of N-formylamphetamine to amphetamine 
by TLC was performed in the plant. The conclusion that the synthetic route was 
Leuckart reaction was made because of the presence of compound 8. 
 
Fig. 6. Mass spectra of unidentified compounds: (a) compound 11; (b) compound 13; 
(c) compound 24; (d) compound 32. 
Among the impurities detected in the analyzed tablets are all the impurities 
also contained in the powder substances (compounds 3, 4, 5, 6, 8, 9, 10, 11, 12, 
13, 15, 17, 19, 20, 22, 24 and 31 listed in Table II and shown in Figs. 3 and 4). 
The impurity profiling chromatograms of selected tablets from case I, II and III, 
the chemical characterization of which were given in Tables I and II, are shown 
in Fig. 4. 
The analyzed white tablets (5 types) found at different locations in the tablet-
-making plant (case I) had a relatively similar characteristic impurity profile, as 
they contained solely amphetamine sulfate. The main impurity was compound 20. 
The content of impurities, i.e., their relative main impurity concentration ratio, 
varied more in the colored tablets (15 types), which could be explained by the pre-
sence of a mixture of amphetamine salts. However, this evidence is not conclu-
sive, as the origin of the production batches could not be determined. The main 
impurities in these cases were compounds 10, 20 and 8. 
In some tablets, ephedrine/pseudoephedrine was identified (Rt = 9.04 min), 
for which it is supposed that it was present as a contaminant from the tablet-ma-
king process, or a deliberately added adulterant. 
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In tablets containing aminopyrine (Fig. 4, chromatograms I-20 and I-22) the 
peak at retention time 26.24 min belongs to the unidentified compound 32, the 
mass spectrum of which is shown in Fig. 6d. 
Impurity profiling of tablets from cases II and III (Fig. 4, chromatograms II-8 
and III-1) shows their essential similarity in the presence of compound 20, as the 
main impurity, and compounds 8, 9 and 10, as well as a significant dissimilarity 
from the profile of all the tablets from case I. 
CONCLUSION 
It was established that the amphetamines produced in clandestine labs in Ser-
bia were in the form of sulfates, tartrates and phosphates. The amphetamine tar-
trate form is reported for the first time in the Republic of Serbia. From the results 
of the analysis of the tablets, it should be emphasized that they contained a mix 
of amphetamine salts and a great variety of additives. The complex mixtures of 
additives used included caffeine, quinine, aminopyrine, ranitidine, lactose, glu-
cose, starch, microcrystal cellulose, povidone and/or stearic acid. Although en-
graved with the usual logo previously encountered in captagon, the tablets did 
not contain fenethylline. The presence of the synergically acting amphetamine, 
caffeine and quinine, as well as the characteristic logo, suggest that all the seized 
quantities were intended for the illegal market as surrogate for captagon. The im-
purity profiles of all the analyzed samples show that the synthetic route for am-
phetamine was the Leuckart reaction. 
И З В О Д  
AНАЛИЗА АМФЕТАМИНА ИЛЕГАЛНО ПРОИЗВЕДЕНОГ У СРБИЈИ 
МАРИНА НЕВЕШЋАНИН1, СОЊА БАНОВИЋ СТЕВИЋ1, СЛОБОДАН ПЕТРОВИЋ2 и ВЛАТКА ВАЈС3 
1Institut bezbednosti, Kraqice Ane bb, 11000 Beograd, 2Tehnolo{ko–metalur{ki fakultet 
Univerziteta u Beogradu, Karnegijeva 4, 11120 Beograd i 3Hemijski fakultet 
Univerziteta u Beogradu, Studentski trg 16, Beograd 
Форензичка пракса у Републици Србији се први пут срела са илегалном производњом 
амфетамина 2003. године. У овом раду представљени су резултати хемијске карактеризације 
32 врсте узорака амфетамина који потичу из три одвојена случаја у циљу идентификације 
активних компоненти и адитива. Профилисањем нечистоћа свих узорака помоћу гасно–масене 
спектромeтрије идентификoвaнo je 30 једињења повезаних са амфетамином. Дати су резул-
тати анализа прашкастих тартаратних, сулфатних и фосфатних соли амфетамина као и раз-
личито формулисаних таблета. Анализе нечистоћа су показале да је у свим случајевима син-
теза амфетамина вршена Leuckart-овом реакцијом. 
(Примљено 25. марта 2008) 
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